CClinicalTrials.gg
RecruitingNCT07004166TPR_Z_PainLeakUpdated Jun 4, 2025

Effects of TPR and Z Techniques on Pain and Drug Leakage in Intramuscular Injections

An interventional study of Z-track method and TPR method in Muscle Pain and Injection Site Pain, sponsored by Cumhuriyet University. Recruiting at 2 sites in Turkey. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-04.

Sponsored by Cumhuriyet University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This randomized, triple-blind clinical trial compares the effectiveness of Z-track and TPR (traction-pressure-release) techniques in reducing pain and medication leakage during ventrogluteal intramuscular injections. Pain is measured using VAS, and leakage is assessed with a millimeter scale. The study aims to identify a more efficient, less painful injection method.

Read the detailed description

Introduction: Intramuscular (IM) injections are widely used for delivering medications due to their high bioavailability and quick absorption. However, they can cause significant local complications, especially pain, which may affect patient compliance. Various non-pharmacological techniques have been developed to reduce injection pain, including the Z-track method and the more recent TPR (traction-pressure-release) technique, based on the gate control theory of pain. While both aim to minimize pain, TPR has shown promise but lacks research regarding its effect on drug leakage.

Objective: The study aims to compare the effectiveness of TPR and Z-track techniques in reducing pain and drug leakage during IM injections in the ventrogluteal site.

Method: This study is a triple-blind, randomized, two-group clinical trial with a parallel design. A total of 76 patients aged 16-40, prescribed with intramuscular diclofenac sodium, will be recruited. Each participant will receive both techniques-TPR and Z-track-in randomly assigned ventrogluteal muscles. Pain intensity will be measured using a Visual Analog Scale (VAS), and drug leakage will be assessed using millimetric paper and a ruler. All injections will be administered by the same nurse, and evaluation will be performed by blinded assessors.

Conclusion: This research seeks to provide evidence on the efficacy of the TPR technique as a potentially time- and cost-effective alternative to Z-track, particularly in minimizing injection-related pain and leakage, thereby improving patient comfort and treatment adherence.

02

Conditions studied

  • Muscle Pain
  • Injection Site Pain

Browse trials for

Keywords

  • Intramuscular Injection
  • Drug Leakage l
  • Pain
  • Z-Track
  • TPR Techniques
03

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Aged 16-40
  • Prescribed diclofenac sodium
  • No communication impairments
  • Healthy ventrogluteal muscles without sensory issues

Exclusion criteria

Exclusion Criteria:

  • Wounds, redness, bruising, tenderness, or stiffness at the injection site
  • Injection in the past 2 weeks
  • Neuropathy or other medical conditions
  • BMI below 15 or above 35
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    TPR (traction-pressure-release) technique

    Intervention Type: Intramuscular drug administration with TPR technique Intervention Name: Diclofenac Sodium TPR method, while the needle is inserted at a 90-degree angle, deep pressure will be applied to the muscle, then rapidly released to create a snapping motion that facilitates the injection. This technique relies on rapid muscle relaxation rather than needle movement by the dominant hand.

    Other: TPR method

  • Experimental
    Z-track method

    Intervention Type: Intramuscular drug administration with Z-track method Intervention Name: Diclofenac Sodium Z-track method, the skin will be pulled laterally by 2.5-3.5 cm before needle insertion at a 90-degree angle. After aspiration and injection, the needle will be withdrawn and the skin released immediately.

    Other: Z-track method

Interventions

  • OtherZ-track method

    Z-track method, the skin will be pulled laterally by 2.5-3.5 cm before needle insertion at a 90-degree angle. After aspiration and injection, the needle will be withdrawn and the skin released immediately.

  • OtherTPR method

    TPR method, while the needle is inserted at a 90-degree angle, deep pressure will be applied to the muscle, then rapidly released to create a snapping motion that facilitates the injection. This technique relies on rapid muscle relaxation rather than needle movement by the dominant hand.

05

What researchers measure

Primary outcomes

  1. Pain with visual analog scale

    Pain intensity measured with the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst possible pain). Higher scores indicate greater pain.

    Time frame: Within 5 minutes after intramuscular injection

Secondary outcomes

  1. Drug leakage

    millimeter ruler to assess medication leakage

    Time frame: Time Frame: Immediately after injection (within 1 minute)Description: Drug leakage will be observed immediately after intramuscular injection by checking the injection site for any visible medication leakage.

06

Study locations

2 of 2 sites recruiting
  • Sivas Numune Hospital
    Sivas, 58000, Turkey
    Recruiting
  • Sivas State Hospital
    Sivas, 58000, Turkey
    • murat yıldırım, phd · Contact · mrtylldrm@gmail.com · 903462795075
    • Hülya KOÇYİĞİT KAVAK, Phd · Principal investigator
    • Şeyda Kazanç, Phd · Sub investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: No — I would like to share the research after it is completed.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07004166
Lead sponsor
Cumhuriyet University
Responsible party
Hulya Kocyigit (Phd, Research Assitant, Cumhuriyet University) — Principal investigator
First posted
Jun 4, 2025
Start date
Jun 15, 2025 (estimated)
Primary completion
Aug 20, 2025 (estimated)
Completion
Aug 25, 2025 (estimated)
Last update
Jun 4, 2025

Study contacts

Hülya KOÇYİĞİT KAVAK, Phd
Contact
hkocyigit@cumhuriyet.edu.tr
90555408876
Şeyda Kazanç, Phd
study director · but no location

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion